Reviewed for legal accuracy by Gary Matthews, Solicitor · Last reviewed: June 2026 · Republic of Ireland only

What does a smear test misread mean in Ireland?

A "misread smear" means the laboratory interpretation of your cervical screening sample was wrong. A sample that should have been flagged was instead reported as clear, so no further investigation followed. To see where that error can happen, it helps to know how Irish screening works today. The pathway changed after the events that made this topic well known.

To put the issue in context, around 290 women are diagnosed with cervical cancer in Ireland each year, and roughly 170 of them had previously attended screening.⁹ So a screening history sits behind a large share of cases, though attending screening does not, on its own, mean a misread occurred. Incidence has been falling since 2010, after the national programme began in 2008.¹⁰

Since March 2020, the national CervicalCheck programme screens for high-risk HPV first. It only examines the cells under a microscope (cytology) when HPV is detected.⁴ HPV testing is more sensitive than the older cytology-first "smear test" (around 90% versus roughly 70%).⁴ That higher sensitivity is why Ireland moved to it. In practice, a present-day interpretation error can occur at more than one point in the pathway:

Within the cytology step, two distinct error routes can found a claim. The first is the one most people picture: suspicious material was present on the sample but was reported as clear. The second is less well known but just as important. Here the sample was inadequate, for example too few cells to give a reliable result, yet it was passed as clear instead of being recalled for a repeat.⁵ Either route can mean a precancerous change went undetected when it could have been treated.

What standard must a screener meet? The Morrissey "no doubt" test

The governing authority is the Supreme Court's decision in Morrissey v Health Service Executive [2020] IESC 6.¹ It's the case every misread-smear claim in Ireland is measured against. So it's worth understanding what it actually decided, rather than the headline figure.

In the High Court, the trial judge had described the screener's duty using the words "absolute confidence", drawing on earlier English authority on cervical screening.⁶ That phrasing caused real alarm in the medical community, which read it as demanding an impossible standard of certainty from a human screener looking down a microscope. On appeal, the Supreme Court settled the point and corrected the impression. It held that "absolute confidence" was never a separate, stricter legal test. It described only the practical approach a careful screener takes, and the actual legal standard remained the ordinary one. The operative rule is this: a screener should not give a clear result unless they have no doubt that the sample is adequate and does not contain any suspicious material.¹ Crucially, this is not a new test of perfection. It's the long-standing Irish negligence test from Dunne v National Maternity Hospital, applied to the task of screening.² The practical effect is that an honest difference of opinion between two competent screeners is not negligence, but reporting a sample as clear where a competent screener would have had a doubt is.

The judgment also drew a distinction that competitors rarely explain, and that is genuinely useful for assessing your own situation. The Court separated the "standard of approach" from the "standard of care".¹ The standard of approach is the factual standard a competent screener applies in practice. The standard of care is the legal duty a court uses to decide negligence. The practical question becomes simple: looking at your actual sample, could a competent screener have given a clear result, or could they not? If a competent screener could not reasonably have cleared it, the reading falls below the standard.

One further point matters for who you can claim against. The Supreme Court found that the HSE was not vicariously liable for the private laboratories. But it owed a non-delegable duty to patients who used CervicalCheck. Outsourcing the slide-reading did not move that responsibility. So the HSE can be primarily liable for negligent reading carried out by an outside lab.¹

That duty matters because the three interpretation points in the pathway can involve different parties. An error in the HPV test or the triage cytology is, in practice, a laboratory error, though the HSE's non-delegable duty means it can be joined regardless of who held the testing contract. A failure to act on an abnormal result, such as not referring an eligible patient onward for colposcopy, points instead toward the clinic or the programme. Part of the early legal work is identifying which step failed, because that shapes who the correct defendants are. The reassuring part for a patient is that the HSE's non-delegable duty means the claim does not collapse simply because the reading was outsourced to a private or overseas lab.

How do you prove breach and causation when a smear is misread?

Proving a smear test misread claim turns on two things, and they are separate. Breach means the reading fell below the Morrissey standard. Causation means that failure actually changed your outcome.

On breach, a pure misread-smear case usually turns on independent expert review of the original material. The sequence in practice runs in a fairly set order. First, the original slides or liquid-based sample are located and retrieved, often from the laboratory that performed the original reading or from the screening programme's records. Second, an independent consultant cytopathologist re-examines that material, blind to the original result where possible, and gives an opinion on whether a competent screener could have reported it as clear. Third, where that independent read differs from the original, the resulting discordance is recorded. That documented discordance is often the trigger that opens the question of negligence, and it is the same kind of finding that emerged from the retrospective clinical audits in the CervicalCheck cases. One practical challenge is worth knowing early. Slides and samples can degrade, be archived, or become difficult to retrieve as years pass, and the original material is usually irreplaceable. That's one reason prompt advice and early expert instruction matter, particularly where the original test was some years ago.

The HSE's own Personal Review process shows how close the medical finding sits to the legal test. That review looks at your cytology samples and HPV results from the ten years before diagnosis, and reports its result in plain categories.¹¹ One category is that the reviewers saw differences on the earlier sample that a skilled screener would not have been expected to pick up at the time, because they were genuinely difficult to find. Another is that the reviewers saw differences that a skilled screener would have been expected to pick up. That second category maps directly onto the Morrissey "no doubt" standard, and a finding in those terms is strong evidence of breach. The Personal Review is not itself a legal claim, but its report can be the document that makes a claim viable.

On causation, the question is whether earlier detection would've changed things. Usually that means asking whether it would have allowed treatment of a precancerous change before it became an invasive cancer, or treatment at an earlier stage with better options. Because the error happens at the screening stage, causation is frequently analysed through the lens of a lost opportunity for earlier intervention. We explain that doctrine in our guide to loss of chance in cancer claims, and the underlying clinical-negligence test on our breach of duty page.

It bears repeating, because it's the most common misunderstanding. A normal result followed by a cancer diagnosis is not, on its own, proof of negligence. Some cancers appear in the interval between a genuinely clear screen and the next one, with no error having been made. Morrissey expressly rejects holding screeners to a standard of perfection.² The claim depends on the specific reading, not on hindsight.

What can a misread-smear claim include?

Where a claim succeeds, compensation in Ireland has two parts. General damages cover the injury, pain and suffering. Special damages cover financial losses such as care, treatment costs and lost earnings. Awards are assessed under the Personal Injuries Guidelines and depend entirely on the individual facts, including how much the delay changed the diagnosis and treatment. The amounts are highly fact-specific, so we've kept the detail on a dedicated page rather than quoting figures here. See cancer misdiagnosis compensation amounts, and, where a delay has shortened life expectancy, reduced life expectancy claims. We do not provide compensation estimates or calculators, and no solicitor can promise an outcome.

How long do you have to claim, and when does the clock start?

The general rule is that a clinical-negligence claim must be brought within two years less one day. But the clock usually does not start on the day of the misread itself. Under the date-of-knowledge rule, time typically runs from when you knew, or could reasonably have known, that an earlier smear was misread and that it was connected to your injury.⁷ In screening cases, that point is often the moment you receive an independent slide review or are told of an audit finding. That can be years after the original test. The rules are fact-sensitive, and there are special provisions for fatal cases. Deadlines can end a claim regardless of its merits, so this is something to check early. We set out the detail on our date of knowledge for cancer claims page.

How do you find out if your smear was misread?

If you suspect an earlier result was wrong, there's a practical order to follow. The aim at this stage is to gather information and preserve evidence, not to predict an outcome.

1. Request your screening records. You can ask the National Screening Service for your CervicalCheck records, and you can ask for your previous slides to be released for independent review. The contact point is CervicalCheck Client Services, National Screening Service, King's Inns House, 200 Parnell Street, Dublin 1, or Freephone 1800 45 45 55.¹¹
2. Consider a Personal Review. If you had a cervical cancer diagnosis and a CervicalCheck test in the ten years before it, you can request a free, independent Personal Review of your screening history.¹¹ It reviews your slides, HPV results, colposcopy care and any biopsy results. It's a review, not a claim, but its findings can inform one.
3. Get independent legal advice early. A solicitor can run the legal analysis alongside any review, instruct an independent cytopathologist, and protect your time limit. Acting early matters most where the original test was years ago and the material needs to be preserved.

A Personal Review and a legal claim can run in parallel. The review tells you what the screening got wrong. The claim decides whether that failure is legally compensable and, if so, recovers compensation.

How do cervical-screening claims proceed now?

If you are researching this, you may have read about the CervicalCheck Tribunal. It's important to be clear. The Tribunal was dissolved on 30 January 2026 and made no awards during its lifetime.³ Cervical-screening claims now proceed through the High Court Clinical Negligence List, under Practice Directions HC131 and HC132, which took effect on 28 April 2025.⁸ Clinical negligence claims bypass the Injuries Resolution Board and go directly to litigation. There is also a separate, non-litigation option: the patient-requested Personal Review of screening results. But that is a review process, not a way of obtaining compensation, and should not be confused with bringing a claim. For wider issues with the screening programme itself, see our cervical screening negligence guide. The general principles that apply whenever a scan, smear or biopsy is misread are on our misread scan, biopsy or histopathology page.

Common questions